Applied Filters
Vir Biotech partners with WuXi on COVID-19 antibody treatment
Immunology-focused Vir Biotechnology and Hong Kong-based WuXi Biologics have become the latest companies to turn their focus to developing treatments for the novel coronavirus.
GSK and Chinese biotech unite for coronavirus vaccine development
British drugmaker GSK and Chinese biotech Clover Biopharmaceuticals have partnered to develop a protein-based coronavirus vaccine candidate.
Indian drugmaker joins race to find COVID-19 vaccine
Indian drugmaker Zydus Cadila has launched a fast track programme to develop a vaccine for the novel coronavirus COVID-19, which has so far claimed more than 1,600 lives worldwide.
Chinese institute tries to patent Gilead coronavirus drug
A state-run institution in China has applied for a patent on the use of an experimental Gilead Sciences drug, which scientists believe may be able to fight the coronavirus outbreak that has killed hundreds.
Bayer settles fungicide trade secrets claims
Bayer has dropped trade secrets claims against a former employee and rival company, which it had accused of stealing confidential information related to organic fungicides.
Bausch Health resolves patent litigation with Glenmark
Canadian pharmaceutical company Bausch Health and India-based Glenmark Pharmaceuticals have resolved their outstanding IP litigation over Bryhali lotion.
Astellas doubles down on gene therapy with $3bn Audentes deal
Astellas is set to buy US-based Audentes Therapeutics for approximately $3 billion, as the Japanese pharmaceutical company looks to boost its gene therapy expertise.
Merck KGaA secures CRISPR patents in Japan and Singapore
The Japan Patent Office and the Intellectual Property Office of Singapore have each granted Merck KGaA a patent covering the use of paired CRISPR nickases.
Chinese state-owned chemical firm in fungicide patent suit
A Chinese state-owned chemical firm is suing US crop protection products company Atticus for patent infringement.
Novartis takes aim at Indian drug companies over Entresto generics
Swiss pharmaceutical company Novartis has filed a patent infringement lawsuit against three Indian rivals in a US federal court over proposed generics of its heart failure drug Entresto.
